Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-196a-5p


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 1228, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
FOXO1 hsa-miR-196a-5p low: 5 high: 0 1 3 1 0.594
Low-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Liu Xiang-hua et al. 2012 WB qP Lung SPCA1 N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 7.0
UNKNOWN qPCR POSITIVE INDIRECT TarBase 7.0
Liu Xiang-hua et al. 2012 WB qP Lung A549 N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 7.0
UNKNOWN qPCR POSITIVE INDIRECT TarBase 7.0
Liu Xiang-hua et al. 2012 RP Lung NSCLC HEK293T N/A
Location Method Result Regulation Validation Type Source
chr13:40558572-40558594 Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
NFKBIA hsa-miR-196a-5p low: 2 high: 2 3 3 3 -
Low-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Huang F et al. 2014 RP Pancreas Pancreatic Cancer Cell Lines PANC1 N/A
Location Method Result Regulation Validation Type Source
chr14:35401616-35401637 Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
Huang F et al. 2014 WB Pancreas Pancreatic Cancer Cell Lines N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 7.0
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr14:35402819-35402841 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr14:35402819-35402841 PAR-CLIP POSITIVE DIRECT TarBase 7.0
HOX-C8(hsa) hsa-miR-196a-5p low: 2 high: 0 1 1 1 -
Low-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Daniel W Mueller et al. 2011 WB qP N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 6.0
UNKNOWN qPCR POSITIVE INDIRECT TarBase 6.0
CDKN1B hsa-miR-196a-5p low: 1 high: 7 5 7 5 0.757
Low-throughput experiments (0 positive, 1 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Carlos le Sage et al. 2007 RP Mammary Gland MCF7 MCF7 N/A
Location Method Result Regulation Validation Type Source
chr12:12721054-12722332 Luciferase Reporter Assay NEGATIVE DIRECT TarBase 8.0
High-throughput experiments (7 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Grosswendt S et al. 2014 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:12721258-12721285 Chimeric fragments POSITIVE DIRECT TarBase 8.0
chr12:12722115-12722144 Chimeric fragments POSITIVE DIRECT TarBase 8.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr12:12721253-12721279 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr12:12721253-12721279 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:12721253-12721279 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:12721253-12721279 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:12721253-12721279 PAR-CLIP POSITIVE DIRECT TarBase 7.0
HMGA2 hsa-miR-196a-5p low: 1 high: 4 5 5 3 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Palmieri D. et al. 2012 RP Bone Marrow MEG01 MEG01 N/A
Location Method Result Regulation Validation Type Source
chr12:65964469-65965862 Luciferase Reporter Assay POSITIVE DIRECT TarBase 8.0
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Grosswendt S et al. 2014 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:65965794-65965819 Chimeric fragments POSITIVE DIRECT TarBase 8.0
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr12:65965798-65965818 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr12:65964532-65964553 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr12:65964532-65964553 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HOXA5 hsa-miR-196a-5p low: 1 high: 2 3 2 2 0.998
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Liu Xiang-hua et al. 2012 RP Lung NSCLC HEK293T N/A
Location Method Result Regulation Validation Type Source
chr7:27141387-27141408 Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Grosswendt S et al. 2014 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:27141384-27141408 Chimeric fragments POSITIVE DIRECT TarBase 8.0
Kishore S et al. 2011 IP Kidney HEK293 N/A mild MNase digestion
Location Method Result Regulation Validation Type Source
chr7:27141387-27141415 PAR-CLIP POSITIVE DIRECT TarBase 7.0
CDK6 hsa-miR-196a-5p low: 1 high: 1 2 2 2 0.550
Low-throughput experiments (0 positive, 1 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Huang F et al. 2014 WB Pancreas Pancreatic Cancer Cell Lines N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot NEGATIVE INDIRECT TarBase 7.0
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr7:92613151-92613173 PAR-CLIP POSITIVE DIRECT TarBase 7.0
CCND1 hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (0 positive, 1 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Huang F et al. 2014 WB Pancreas Pancreatic Cancer Cell Lines N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot NEGATIVE INDIRECT TarBase 7.0
ANXA1 hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
R Luthra et al. 2008 RP Mammary Gland MCF7 MCF7 N/A
Location Method Result Regulation Validation Type Source
chr9:73170198-73170217 Luciferase Reporter Assay POSITIVE DIRECT TarBase 6.0
cadherin-1(hsa) hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Daniel W Mueller et al. 2011 qP N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN qPCR POSITIVE INDIRECT TarBase 6.0
calponin-1(hsa) hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Daniel W Mueller et al. 2011 qP N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN qPCR POSITIVE INDIRECT TarBase 6.0
VIM hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (0 positive, 1 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Huang F et al. 2014 WB Pancreas Pancreatic Cancer Cell Lines N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot NEGATIVE INDIRECT TarBase 7.0
CDH1 hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Huang F et al. 2014 WB Pancreas Pancreatic Cancer Cell Lines N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 7.0
GNPDA1 hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 WB Cervix HELA N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 7.0
CDK4 hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (0 positive, 1 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Huang F et al. 2014 WB Pancreas Pancreatic Cancer Cell Lines N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot NEGATIVE INDIRECT TarBase 7.0
CDH2 hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (0 positive, 1 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Huang F et al. 2014 WB Pancreas Pancreatic Cancer Cell Lines N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot NEGATIVE INDIRECT TarBase 7.0
Hugl-1(hsa) hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Daniel W Mueller et al. 2011 qP N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN qPCR POSITIVE INDIRECT TarBase 6.0
osteopontin(hsa) hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Daniel W Mueller et al. 2011 qP N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN qPCR POSITIVE INDIRECT TarBase 6.0
HMGA1 hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Palmieri D. et al. 2012 RP Bone Marrow MEG01 MEG01 N/A
Location Method Result Regulation Validation Type Source
chr6:34245848-34246188 Luciferase Reporter Assay POSITIVE DIRECT TarBase 8.0
MT-ND5 hsa-miR-196a-5p low: 0 high: 7 2 2 2 -
High-throughput experiments (7 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Grosswendt S et al. 2014 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chrMT:13811-13837 Chimeric fragments POSITIVE DIRECT TarBase 8.0
Moore M et al. 2015 IP Liver HUH7.5 N/A N/A
Location Method Result Regulation Validation Type Source
chrMT:13229-13304 CLEAR-CLIP POSITIVE DIRECT TarBase 8.0
chrMT:13758-13833 CLEAR-CLIP POSITIVE DIRECT TarBase 8.0
chrMT:13552-13695 CLEAR-CLIP POSITIVE DIRECT TarBase 8.0
chrMT:13083-13158 CLEAR-CLIP POSITIVE DIRECT TarBase 8.0
chrMT:12680-12755 CLEAR-CLIP POSITIVE DIRECT TarBase 8.0
chrMT:12492-12567 CLEAR-CLIP POSITIVE DIRECT TarBase 8.0